(Q27676429)

4

object named as

Haim Rozenberg

0 references

author name string

Netta Sela-Passwell

1

0 references

Raghavendra Kikkeri

2

0 references

Orly Dym

3

0 references

Raanan Margalit

5

0 references

Rina Arad-Yellin

6

0 references

Ori Brenner

8

0 references

Tsipi Shoham

9

0 references

Tamar Danon

10

0 references

Abraham Shanzer

11

0 references

Irit Sagi

Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1

12

0 references

language of work or name

English

0 references

publication date

25 December 2011

0 references

published in

Nature Medicine

0 references

volume

18

0 references

issue

1

0 references

page(s)

143-7

0 references

cites work

1 reference

The intrinsic protein flexibility of endogenous protease inhibitor TIMP-1 controls its binding interface and affects its function

22 April 2017

1 reference

Crystal structure of human MMP9 in complex with a reverse hydroxamate inhibitor

22 April 2017

1 reference

Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed

22 April 2017

1 reference

Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations

22 April 2017

1 reference

Matrix metalloproteinases and the regulation of tissue remodelling

22 April 2017

1 reference

Inflammatory bowel disease

22 April 2017

1 reference

Future challenges facing the development of specific active-site-directed synthetic inhibitors of MMPs

22 April 2017

1 reference

Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis.

21 January 2018

1 reference

Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor

21 January 2018

1 reference

Structure and function of matrix metalloproteinases and TIMPs

21 January 2018

1 reference

Matrix metalloproteinase-9-mediated tissue injury overrides the protective effect of matrix metalloproteinase-2 during colitis

21 January 2018

1 reference

Catalytic domain architecture of metzincin metalloproteases.

21 January 2018

1 reference

Conformational variability of matrix metalloproteinases: beyond a single 3D structure

21 January 2018

1 reference

Antibody-antigen interactions: contact analysis and binding site topography.

21 January 2018

1 reference

Hydrophobic complementarity in protein-protein docking

21 January 2018

1 reference

Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn's disease

21 January 2018

1 reference

Attenuation of dextran sodium sulphate induced colitis in matrix metalloproteinase-9 deficient mice.

21 January 2018

1 reference

Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP.

21 January 2018

1 reference

New mediators of immunity and inflammation in inflammatory bowel disease

21 January 2018

1 reference

Selective ablation of matrix metalloproteinase-2 exacerbates experimental colitis: contrasting role of gelatinases in the pathogenesis of colitis.

21 January 2018

1 reference

Evolving knowledge and therapy of inflammatory bowel disease

21 January 2018

1 reference

Quantitative analysis of intravenously administered contrast media reveals changes in vascular barrier functions in a murine colitis model.

21 January 2018

1 reference

Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.

21 January 2018

1 reference

A selective matrix metalloproteinase-12 inhibitor retards atherosclerotic plaque development in apolipoprotein E-knockout mice

21 January 2018

1 reference

Third generation of matrix metalloprotease inhibitors: Gain in selectivity by targeting the depth of the S1' cavity.

21 January 2018

1 reference

Matrix metalloproteinase proteomics: substrates, targets, and therapy.

21 January 2018

1 reference

Avoiding spam in the proteolytic internet: future strategies for anti-metastatic MMP inhibition.

21 January 2018

1 reference

Pronounced diversity in electronic and chemical properties between the catalytic zinc sites of tumor necrosis factor-alpha-converting enzyme and matrix metalloproteinases despite their high structural similarity.

21 January 2018

1 reference

Chemically induced mouse models of intestinal inflammation

21 January 2018

1 reference

Expression of matrix metalloproteinases-2 and -9 in intestinal tissue of patients with inflammatory bowel diseases

21 January 2018

1 reference

12 December 2020

Matrix metalloproteinase levels are elevated in inflammatory bowel disease

1 reference

12 December 2020

A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases

1 reference

12 December 2020

New opportunities in drug design of metalloproteinase inhibitors: combination between structure-function experimental approaches and systems biology

1 reference

12 December 2020

Potent mechanism-based inhibitors for matrix metalloproteinases

1 reference

12 December 2020

Structure of the C-terminally truncated human ProMMP9, a gelatin-binding matrix metalloproteinase

1 reference

12 December 2020